| Cat. No. | 
                Product Name | 
                
                Information | 
            
            
                
            	| PC-38748 | 
                
                	
                		 APJ agonist 47 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                APJ agonist 47 is a potent and selective, orally active apelin receptor (APJ) agonist EC50 of 6.5 nM. | 
            
            
                
            	| PC-38139 | 
                
                	
                		 CMF-019 
                       
                  	
                    APJ receptor agonist 
                 | 
                
                CMF-019 (CMF019) is the first G protein biased small molecule Apelin receptor (APJ, APLNR) agonist, potent benzimidazole-derived apelin peptidomimetic, binds to APLNR with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse APLNR, respectively. | 
            
            
                
            	| PC-38138 | 
                
                	
                		 BMS-986224 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                BMS-986224 (BMS986224) is a novel potent, selective, orally bioavailable agonist of Apelin receptor (APJ, APLNR) with Ki of 0.074 nM (human APJ). | 
            
            
                
            	| PC-38137 | 
                
                	
                		 AM-8123 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                AM-8123 (AM8123) is a small-molecule agonist of Apelin receptor (APJ, APLNR), inhibits forskolin-stimulated cAMP production (pEC50=9.44) and promoted Gα protein activation (pEC50=8.95). | 
            
            
                
            	| PC-38136 | 
                
                	
                		 AMG986 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                AMG986 (Azelaprag, AMG-986) is a small-molecule agonist of Apelin receptor (APJ, APLNR), inhibits forskolin-stimulated cAMP production (pEC50=9.64) and promoted Gα protein activation (pEC50=9.54). | 
            
            
                
            	| PC-63277 | 
                
                	
                		 ML221 
                       
                  	
                    Apelin receptor antagonist 
                 | 
                
                ML221 is a potent, selective, functional antagonist of apelin receptor (APJ) with IC50 of 1.75 uM in the β-arrestin assay, >37-fold selective over the closely related AT1 receptor. | 
            
            
                
            	| PC-24284 | 
                
                	
                		 ML233 
                       
                  	
                    APJ agonist, Tyrosinase inhibitor 
                 | 
                
                ML233 is a small molecule apelin receptor (APJ, APLNR)) agonist, also is a potent inhibitor of tyrosinase (TYR) activity in vivo and in vitro. | 
            
            
                
            	| PC-23721 | 
                
                	
                		 Apelin receptor agonist cmpd644 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                Apelin receptor agonist cmpd644 is a potent small-molecule agonist of apelin receptor (APJR). | 
            
            
                
            	| PC-22059 | 
                
                	
                		 WN561 
                       
                  	
                    Apelin receptor agonist 
                 | 
                
                WN561 (WN-561) a potent, selective non-hypertrophic and fully G-protein-biased apelin receptor (APLNR, APJ) agonist, exhibits cardioprotective functions with reduced cardiac hypertrophy. |